Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fay

Showing results (361-370 of 395) with videos related to

Pageof 40
Sort By:
The Journal of Clinical Investigation|August 10, 2023
A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndromeDavid H McDermott, Daniel Velez, Elena Cho, et al.
Nature Genetics|September 7, 2022
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulationSylvan C Baca, Cassandra Singler, Soumya Zacharia, et al.
Vaccine|May 12, 2009
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in MaliIssaka Sagara, Alassane Dicko, Ruth D Ellis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 19, 2022
An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic SyndromesMichael M Chen, Florence Roufosse, Sa A Wang, et al.
Nature Communications|June 17, 2023
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administrationDean Follmann, Meagan P O'Brien, Jonathan Fintzi, et al.
Plos One|July 2, 2021
Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus diseaseNancy A Niemuth, Dawn Fallacara, Cheryl A Triplett, et al.
Allergy|August 16, 2022
Urine eosinophil-derived neurotoxin: A potential marker of activity in select eosinophilic disordersMichelle A Makiya, Paneez Khoury, Fei Li Kuang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2016
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaDavid J Kwiatkowski, Toni K Choueiri, André P Fay, et al.
The Lancet. Infectious Diseases|August 1, 2018
Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adultsIssaka Sagara, Sara A Healy, Mahamadoun H Assadou, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2021
A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)Fernando C Maluf, Fabio A Schutz, Eduardo H Cronemberger, et al.
Pageof 40

Showing results (361-370 of 395) with videos related to

Sort By:
Pageof 40
The Journal of Clinical Investigation|August 10, 2023
A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndromeDavid H McDermott, Daniel Velez, Elena Cho, et al.
Nature Genetics|September 7, 2022
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulationSylvan C Baca, Cassandra Singler, Soumya Zacharia, et al.
Vaccine|May 12, 2009
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in MaliIssaka Sagara, Alassane Dicko, Ruth D Ellis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 19, 2022
An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic SyndromesMichael M Chen, Florence Roufosse, Sa A Wang, et al.
Nature Communications|June 17, 2023
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administrationDean Follmann, Meagan P O'Brien, Jonathan Fintzi, et al.
Plos One|July 2, 2021
Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus diseaseNancy A Niemuth, Dawn Fallacara, Cheryl A Triplett, et al.
Allergy|August 16, 2022
Urine eosinophil-derived neurotoxin: A potential marker of activity in select eosinophilic disordersMichelle A Makiya, Paneez Khoury, Fei Li Kuang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2016
Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell CarcinomaDavid J Kwiatkowski, Toni K Choueiri, André P Fay, et al.
The Lancet. Infectious Diseases|August 1, 2018
Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adultsIssaka Sagara, Sara A Healy, Mahamadoun H Assadou, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2021
A phase 2 randomized clinical trial of abiraterone plus ADT, apalutamide, or abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels (LACOG 0415)Fernando C Maluf, Fabio A Schutz, Eduardo H Cronemberger, et al.
Pageof 40